These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 32336039)

  • 1. Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions.
    Osataphan N; Phrommintikul A; Chattipakorn SC; Chattipakorn N
    J Cell Mol Med; 2020 Jun; 24(12):6534-6557. PubMed ID: 32336039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial aldehyde dehydrogenase protects against doxorubicin cardiotoxicity through a transient receptor potential channel vanilloid 1-mediated mechanism.
    Ge W; Yuan M; Ceylan AF; Wang X; Ren J
    Biochim Biophys Acta; 2016 Apr; 1862(4):622-634. PubMed ID: 26692169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mitochondria in doxorubicin-mediated cardiotoxicity: From molecular mechanisms to therapeutic strategies.
    Wang T; Xing G; Fu T; Ma Y; Wang Q; Zhang S; Chang X; Tong Y
    Cell Stress Chaperones; 2024 Apr; 29(2):349-357. PubMed ID: 38485043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mitochondria in doxorubicin-mediated cardiotoxicity: from molecular mechanisms to therapeutic strategies.
    Wang T; Xing G; Fu T; Ma Y; Wang Q; Zhang S; Chang X; Tong Y
    Int J Med Sci; 2024; 21(5):809-816. PubMed ID: 38617011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity.
    Wu L; Wang L; Du Y; Zhang Y; Ren J
    Trends Pharmacol Sci; 2023 Jan; 44(1):34-49. PubMed ID: 36396497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.
    Iarussi D; Indolfi P; Casale F; Martino V; Di Tullio MT; Calabrò R
    Paediatr Drugs; 2005; 7(2):67-76. PubMed ID: 15871628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
    Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
    Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts.
    Jain A; Rani V
    Mol Cell Biochem; 2018 May; 442(1-2):81-96. PubMed ID: 28929270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.
    Henninger C; Huelsenbeck S; Wenzel P; Brand M; Huelsenbeck J; Schad A; Fritz G
    Pharmacol Res; 2015 Jan; 91():47-56. PubMed ID: 25462173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity.
    Wu BB; Leung KT; Poon EN
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-Targeting Small Molecules Effectively Prevent Cardiotoxicity Induced by Doxorubicin.
    Shi W; Deng H; Zhang J; Zhang Y; Zhang X; Cui G
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29921817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.
    Koleini N; Kardami E
    Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity.
    Saleme B; Gurtu V; Zhang Y; Kinnaird A; Boukouris AE; Gopal K; Ussher JR; Sutendra G
    Sci Transl Med; 2019 Feb; 11(478):. PubMed ID: 30728290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect.
    Huang J; Wu R; Chen L; Yang Z; Yan D; Li M
    Front Pharmacol; 2022; 13():811406. PubMed ID: 35211017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches.
    Sheibani M; Azizi Y; Shayan M; Nezamoleslami S; Eslami F; Farjoo MH; Dehpour AR
    Cardiovasc Toxicol; 2022 Apr; 22(4):292-310. PubMed ID: 35061218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of iron in the potentiation of anthracycline cardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction.
    Link G; Tirosh R; Pinson A; Hershko C
    J Lab Clin Med; 1996 Mar; 127(3):272-8. PubMed ID: 9273360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction.
    Dolinsky VW
    Biol Chem; 2017 Aug; 398(9):955-974. PubMed ID: 28253192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
    Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
    Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.
    Räsänen M; Degerman J; Nissinen TA; Miinalainen I; Kerkelä R; Siltanen A; Backman JT; Mervaala E; Hulmi JJ; Kivelä R; Alitalo K
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13144-13149. PubMed ID: 27799559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
    Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
    Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.